FDA Approves Emrelis (telisotuzumab vedotin-tllv) for High c-MET Expressing NSCLC
Did you know? There are different kinds of changes, called mutations, that can happen in the MET gene. These changes can help cancer grow and spread. One type is called c-MET overexpression. This means the cancer cells make too [...]